Amicus Therapeutics (FOLD) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Amicus Therapeutics (FOLD) over the last 7 years, with Q3 2025 value amounting to $0.06.
- Amicus Therapeutics' EPS (Weighted Average and Diluted) rose 40000.0% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.04, marking a year-over-year increase of 8823.53%. This contributed to the annual value of -$0.18 for FY2024, which is 6385.72% up from last year.
- According to the latest figures from Q3 2025, Amicus Therapeutics' EPS (Weighted Average and Diluted) is $0.06, which was up 40000.0% from -$0.08 recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.06 during Q3 2025, and its lowest value of -$0.31 during Q4 2021.
- Over the past 5 years, Amicus Therapeutics' median EPS (Weighted Average and Diluted) value was -$0.11 (recorded in 2023), while the average stood at -$0.12.
- Examining YoY changes over the last 5 years, Amicus Therapeutics' EPS (Weighted Average and Diluted) showed a top increase of 40000.0% in 2025 and a maximum decrease of 6000.0% in 2025.
- Amicus Therapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.31 in 2021, then soared by 37.01% to -$0.19 in 2022, then soared by 43.08% to -$0.11 in 2023, then skyrocketed by 144.02% to $0.05 in 2024, then increased by 23.91% to $0.06 in 2025.
- Its last three reported values are $0.06 in Q3 2025, -$0.08 for Q2 2025, and -$0.07 during Q1 2025.